Search
Support us
  • RESEARCH
  • PUBLICATIONS
  • RESIDUAL DISEASE POST NEOADJUVANT CHEMO-IMMUNOTHERAPY IN EARLY TRIPLE-NEGATIVE BREAST CANCER: DOES IT HELP TAILOR ADJUVANT TREATMENT?

Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative breast cancer: does it help tailor adjuvant treatment?

  • Show more authors
    + 2
  • E Agostinetto
  • L Buisseret
  • R Salgado
  • M Kok
  • M Ignatiadis

More about this publication

Annals of oncology : official journal of the European Society for Medical Oncology
  • Volume 35
  • Issue nr. 5
  • Pages 409-411
  • Publication date 01-05-2024
Full text links

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.